Early research (Phase 1)Ended earlyNCT02048358
What this trial is testing
Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients
Who this might be right for
Healthy VolunteersMultiple Sclerosis
BBB-Therapeutics B.V. 47